The EU project TEF-Health aims to test and validate innovative artificial intelligence (AI) and robotics solutions for the healthcare sector and accelerate their path to market. It is led by Prof. Petra Ritter, who heads the Brain Simulation Section at the Berlin Institute of Health at Charité (BIH) and at the Department of Neurology and Experimental Neurology of Charité – Universitätsmedizin Berlin. The 51 participating project partners from nine European countries will receive funding to the tune of about €60 million , with half coming from the European Commission under its Digital Europe program and half from national funding agencies. Some €2 million of the EC funding will go to the BIH.

Technological advances in the field of AI and robotics are being made at a breathtaking pace – and the healthcare sector is not spared from these developments. Yet it goes without saying that new medical devices and procedures must first prove their safety and usefulness before they can be adopted in clinical practice. In the European Union, the areas of AI and robotics, which are set to have a far-reaching impact on the healthcare sector, especially have to meet high quality requirements, but there is still a lack of testing infrastructure for developing standards, validating innovations, and certifying new products.

This is precisely where the Testing and Experimentation Facility for Health AI and Robotics (TEF-Health) comes in. The new project, supported by the EC and national funding agencies with a total of about €60 million, aims to “facilitate and accelerate the validation and certification of AI and robotics in medical devices,” explains Prof. Petra Ritter, who coordinates the consortium and heads the Brain Simulation Section at the Berlin Institute of Health at Charité (BIH). Some €2 million of the EU funding will go directly to the BIH at Charité. In total, 51 academic and private partners from nine European countries are involved in the project, integrating existing infrastructures as well as building new ones. The project officially kicked off on 1 January 2023.

Putting new technology through the pace

“With TEF Health we mainly want to test novel AI approaches in real-world scenarios,” says Ritter. This includes new software used in areas such as patient care and diagnostics, as well as devices controlled by artificially intelligent programs, some of which are designed for direct use on humans – such as surgical and nursing robots. “We will evaluate how to facilitate market access and acceptance of these smart technologies,” Ritter reports.

The plan is for the project partners to develop new regulatory and ethical requirements, including, for instance, standardized testing protocols and certifications or a specific code of conduct for use of the technology. In addition, the necessary technical and administrative procedures must be developed and created. Also on board the TEF-Health project are therefore leading hospitals, universities, and clinical research institutions such as Sweden’s Karolinska Institutet, as well as state-designated testing organizations such as German safety inspector TÜV and the National Metrology Institute of Germany and its French counterpart, the “Laboratoire national de métrologie et d'essais,” or LNE for short. The newly created evaluation resources and infrastructure will be made available to industry in the future in the form of fee-based services. “Widespread use of these comprehensive testing and evaluation tools will not only accelerate market access for innovative AI and robotics technologies, but will also ultimately boost public confidence in these new developments,” explains Ritter.

Getting to market faster

The TEF-Health project has the express aim of generating and consolidating sustainable collaborations between industry, academic research, and other players. “Long-term partnerships in innovation networks have shown to provide a particularly favorable environment for the transfer of technology from research to practice,” Ritter explains. “What’s more, close cooperation between the various partners avoids duplicating work already done.” This, she says, makes sure investments are used for highest impact. The close collaboration will also help to ensure that going forward research findings are translated more quickly into new products and services. Ultimately, the entire value chain in AI and robotics technologies for healthcare will benefit from this – which in turn will “increase the prosperity and quality of life of society as a whole,” predicts Ritter.

So in the end, TEF-Health will contribute to Digital Europe’s overall aim of increasing the effectiveness, resilience, and sustainability of European health and care systems and reducing healthcare delivery inequalities in Europe, while ensuring compliance with relevant legal, ethical, quality, and interoperability standards and requirements. Or, in Ritter’s words: “With TEF-Health we want to help ensure that the digital transformation of our healthcare system occurs safely and for the benefit of all – as articulated in the BIH’s mission of “turning research into health.”

Innovative Healthcare and Life Sciences Location in Berlin Brandenburg

The German capital region is one of the world's leading locations in everything related to health and innovation. What makes the region especially strong is the unique concentration and networking of science, clinics, and business.

More than 670 biotech, pharma, and medtech companies benefit from the excellent scientific environment, clinical research landscape, and proximity to policymakers and healthcare professionals. This applies to globally operating companies such as Bayer, B. Braun, Berlin-Chemie, Biotronik, Eckert & Ziegler, Pfizer, Sanofi, Takeda, and Thermo Fisher as well as to the many small and medium-sized companies in the healthcare industries. Added to this is the geographic location of the German capital region, which provides good access to Western, Central, and Eastern European markets.

For further information about the growth industries, economic development, business and technology support for companies, investors and scientific institutions in the Airport Region Berlin Brandenburg please contact

Melanie Gartzke I melanie.gartzke(at)airport-region.de

(Source: BIH 03.02.2023, '€60 million committed to establish AI and robotics in healthcare' from 2nd Jan, 2023)